First FDA-Approved Atypical Antipsychotic Drug for The Treatment of Hallucinations and Delusions Pimavanserin Powder USA Stock

Model NO.
Pimavanserin
Storage
Room Temperature Away From Light
Shelf Life
24month
Shipping
FedEx DHL UPS TNT Fastway
Sample
10gram Available
Application
Parkinson′s Disease 
CAS No.
706779-91-1
Appearance
White to off-White Powder
HPLC
99% HPLC
Trade Name
Nuplazid
Product Name
Pimavanserin
Transport Package
100g, 1kg, 25kg
Specification
100g, 1kg, 25kg
Trademark
Niche
Origin
China
HS Code
2933990099
Production Capacity
100kg/Month
Reference Price
$ 0.72 - 0.99

Product Description

First FDA-approved atypical antipsychotic drug for the treatment of hallucinations and delusions Pimavanserin Powder USA Stock  
 
Product Description

First FDA-Approved Atypical Antipsychotic Drug for The Treatment of Hallucinations and Delusions Pimavanserin Powder USA Stock

Detailed Product Information
 
Product Name : Pimavanserin
T rade Name :   Nuplazid
CAS No. :706779-91-1
Molecular Formula: C25H34FN3O2
Molecular Weight:   427.55g/mol
Purity :  9 9 %  HPLC
Appearance:    W hite  to off-white P owder
Standard Packing :  100g,1kg,25kg 
Typical use : Arypical antipsychotics
Shelf Life  :2 years

Storage : Room temperature away from light
 
First FDA-Approved Atypical Antipsychotic Drug for The Treatment of Hallucinations and Delusions Pimavanserin Powder USA Stock

Description:

Pimavanserin is the active pharmaceutical ingredient of Nuplazid ® , which was approved by the FDA in 2016 for the treatment of hallucinations and delusions associated with psychosis in patients suffering from Parkinson's disease. Its exact mechanism of action is unclear. The drug exhibits a combination of inverse agonist and antagonist activity at the serotonin 2A receptors (5-HT2A) and, to a lesser extent, at the 5-HT2C receptors in the central nervous system, which is believed to contribute to its antipsychotic activity. Pimavanserin is absorbed in the gastrointestinal tract and is highly bound to plasma protein (approximately 95%). Following the administration of a single 34-mg dose of pimavanserin, the time to maximum plasma concentration is six hours, the half-life is approximately 57 h and the mean (standard deviation, SD) apparent volume of distribution is 2,173 (307) L. Pimavanserin is metabolized in the liver predominantly by cytochrome P450 (CYP3A4 and CYP3A5) and does not cause significant CYP3A4 inhibition or induction. It has a major active N-desmethylated metabolite AC-279, whose half-life is 200 h

Recommended Dosage NUPLAZID (pimavanserin) is available as:
 
  • 34 mg strength capsules. The capsules are opaque white and light green with "PIMA" and "34" printed in black.
  • 10 mg strength tablets. The orange, round, coated tablets are debossed on one side with a "P" and "10" on the reverse side

Typical Properties: 
  • Atypical antipsychotics FDA Approved 2016
  • Antidepressant Drug
  • Treatment of hallucinations and delusions associated with  Parkinson's disease   psychosis
R elated Products 
 
No Items CAS FDA Approved  Application
1 Tianeptine Sodium Salt 30123-17-2 - Antidepressant Drugs
2 Tianeptine Sulfate 1224690-84-9 - Antidepressant Drugs
3 Tianeptine Free Acid 66981-73-5 - Antidepressant Drugs
4 Bupropion 34911-55-2 - Antidepressant Drugs
           
6 Brexpiprazole 913611-97-9 2015 Schizophrenia
7 Aripiprazole 129722-12-9 2002 Antidepressant Drugs
8 Vortioxetine Hydrobromide 960203-27-4 2013 Antidepressant Drugs
9 Vilazodone 163521-12-8 2011 Antidepressant Drugs
10 Duloxetine Hydrochloride 136434-34-9 2004 Antidepressant Drugs
11 Venlafaxine Hydrochloride 99300-78-4 1993 Antidepressant Drugs
12 Citalopram Hydrobromide 59729-32-7 1989 Antidepressant Drugs
13 Fluoxertine hydrochloride 59333-67-4 1986 Antidepressant Drugs
14 Quetiapine Fumarate 111974-72-2 1997 Antidepressant Drugs
15 Sertraline Hydrochloride 79559-97-0 1992 Antidepressant Drugs
16 Mianserin hydrochloride 21535-47-7 - Antidepressant Drugs
17 Amitriptyline hydrochloride 549-18-8 - Antidepressant Drugs
18 Clozapine - Schizophrenia
19 Olanzapine 132539-06-1 - Schizophrenia
20 Mirtazapine 85650-52-8 - Antidepressant Drugs
 

 

First FDA-Approved Atypical Antipsychotic Drug for The Treatment of Hallucinations and Delusions Pimavanserin Powder USA Stock
Service
1. Any inquiries will be replied within 12 hours.
2. Dedication to quality, supply & service.
3. Strictly on selecting raw materials.
4. OEM/ODM Available.
5. Reasonable & competitive price, fast lead time.
6. Sample is available for your evaluation & formulation development.

Advantage
1. Faster delivery: Sample order in stock and 3-7 days for bulk production.
2. We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
3. After-Sale Service: 
1)International Authorized Third-Party Test For The Products You Demand. 
2)60 Days Warranty of quality of goods.

Q&A
Q1: How to confirm the Product Quality before placing orders?
A: By sending you our available samples.
Or if you have special requirement on the goods, we can prepare samples according to your requirement for your confirmation.
 
Q2: Can you supply free samples?
A: Yes, we can provide some free sample, but the shipping cost should be on the customers' account. You can either pay the shipping cost or arrange a courier to collect the samples.
 
Q3: What's the MOQ?
A: For the high value product, our MOQ starts from 1g and generally starts from 10g.
For other low value product, our MOQ starts from 100g and 1kg.
 
Q4: How to place order and make payment?
A: You can send our your Purchase order(if your company has), or just send a simple confirmation by email or by TradeManager, and we will send you Proforma Invoice with our bank details for your confirmation, then you can make payment accordingly.
 
Q5: How do you treat quality complaint?
A: All our products are strictly tested by our QC, and confirmed by QA; unqualified  material will not be released to customer. 
In case any quality problem is confirmed to be caused by us, we will replace the goods or refund your payment immediately.

 
Company Profile

First FDA-Approved Atypical Antipsychotic Drug for The Treatment of Hallucinations and Delusions Pimavanserin Powder USA Stock First FDA-Approved Atypical Antipsychotic Drug for The Treatment of Hallucinations and Delusions Pimavanserin Powder USA Stock First FDA-Approved Atypical Antipsychotic Drug for The Treatment of Hallucinations and Delusions Pimavanserin Powder USA Stock First FDA-Approved Atypical Antipsychotic Drug for The Treatment of Hallucinations and Delusions Pimavanserin Powder USA Stock First FDA-Approved Atypical Antipsychotic Drug for The Treatment of Hallucinations and Delusions Pimavanserin Powder USA Stock

First FDA-Approved Atypical Antipsychotic Drug for The Treatment of Hallucinations and Delusions Pimavanserin Powder USA Stock

 

 

PNEUTEC.IT, 2023